Target intelligence / Profile preview

Cytokine-dependent hematopoietic cell linker (CLNK)

Target
CLNK
Molecular classification
Other (Adaptor protein), SH2 domain-containing protein, SLP-76 family
01

Overview

Cytokine-dependent hematopoietic cell linker (CLNK) is a member of the SLP-76 family of SH2-domain–containing adaptor proteins[1][5][9][12]. CLNK is involved in the regulation of immunoreceptor signaling across multiple lymphocyte lineages, including B cells, T cells, natural killer (NK) cells, and mast cells[1][5][9][12]. In B and T cells, it helps coordinate proximal receptor signaling with downstream cascades such as PLC-gamma activation, influencing cell activation, cytokine production, and, in some contexts, cell death pathways such as necroptosis[1][5][12]. While initially implicated in mast cell signaling (thus the alias MIST, "mast cell immunoreceptor signal transducer"), functional studies indicate its role in mast cell degranulation may be redundant or auxiliary[1]. Further, CLNK acts as a regulator (positive or negative depending on the cell context) of T- and NK-cell activation and can modulate immune responses and exhaustion[1][5][12]. Elevated serum CLNK has been observed in transfusion-dependent thalassemia and correlates with iron overload, suggesting potential as a biomarker in certain contexts[7]. There are currently no approved therapeutics targeting CLNK or drugs known to interact specifically with this protein.

Other names
MISTMast cell immunoreceptor signal transducercytokine-dependent hematopoietic cell linkerCLNK
02

Biological functions

Signal transductionRegulation of immunoreceptor signalingB-cell receptor signalingT-cell receptor signalingMast cell degranulationNatural killer cell activationInhibition of interferon-gamma productionT-cell activationCell death (necroptosis)
03

Disease associations

InflammationImmune dysfunctionCancer (indirect regulatory roles suggested)Other (Thalassemia—biomarker association)Neuropsychiatric disease (Alzheimer disease 10, Neurotic excoriation; associations only)
04

Biomarkers

Serum CLNK may be an exploratory biomarker for immune dysregulation and iron overload in transfusion-dependent β-thalassemia[7]

Beyond the preview

Go deeper on Cytokine-dependent hematopoietic cell linker (CLNK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine-dependent hematopoietic cell linker (CLNK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call